Cross-sectional study identifies barriers to medications adherence and follow-up after TIA discharge, suggesting critical areas for improvement.
To evaluate adherence to secondary stroke prevention medications (antiplatelet and/or statin) and outpatient follow-up after TIA discharge, along with identifying barriers to noncompliance and loss to follow-up.
No takes yet. Share an insight, caveat, or question.
Dengri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: